Publications

Hu, Zhibin, Hongxia Ma, Daru Lu, Ji Qian, Jiannong Zhou, Yijiang Chen, Lin Xu, Xinru Wang, Qingyi Wei, and Hongbing Shen. “Genetic variants in the MDM2 promoter and lung cancer risk in a Chinese population..” Int J Cancer 118, no. 5 (March 1, 2006): 1275–78. https://doi.org/10.1002/ijc.21463.

PMID
16152608
Full Text

Liao, Zhongxing, Hongji Liu, Stephen G. Swisher, Luo Wang, Tsung-Teh Wu, Arlene M. Correa, Jack A. Roth, et al. “Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation..” Int J Radiat Oncol Biol Phys 64, no. 3 (March 1, 2006): 700–708. https://doi.org/10.1016/j.ijrobp.2005.08.008.

PMID
16242255
Full Text

Berry, William R. “Systemic therapy for prostate cancer..” N C Med J 67, no. 2 (March 2006): 154–57.

PMID
16752722
Scholars@Duke

Golombeck, K, Ball, RH, Lee, H, Farrell, JA, Farmer, DL, Jacobs, VR, Rosen, MA, Filly, RA, and Harrison, MR. "Maternal morbidity after maternal-fetal surgery." March 2006.

PMID
16522421
Full Text

Poynter, Jenny N., Kathleen A. Cooney, Joseph D. Bonner, Kirsten A. White, Lynn P. Tomsho, Gad Rennert, and Stephen B. Gruber. “APC I1307K and the risk of prostate cancer..” Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 15, no. 3 (March 2006): 468–73. https://doi.org/10.1158/1055-9965.epi-05-0584.

PMID
16537703
Full Text

Crane, Christopher H., Lee M. Ellis, James L. Abbruzzese, Christina Amos, Henry Q. Xiong, Linus Ho, Douglas B. Evans, et al. “Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer..” J Clin Oncol 24, no. 7 (March 1, 2006): 1145–51. https://doi.org/10.1200/JCO.2005.03.6780.

PMID
16505434
Full Text

Beekman, Kathleen W., A Dimitrios Colevas, Kathleen Cooney, Robert Dipaola, Rodney L. Dunn, Mitchell Gross, Evan T. Keller, et al. “Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: scientific rationale and study design..” Clinical Genitourinary Cancer 4, no. 4 (March 2006): 299–302. https://doi.org/10.3816/cgc.2006.n.012.

PMID
16729916
Full Text

Trevino, Jose G., Justin M. Summy, Donald P. Lesslie, Nila U. Parikh, David S. Hong, Francis Y. Lee, Nicholas J. Donato, James L. Abbruzzese, Cheryl H. Baker, and Gary E. Gallick. “Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model..” The American Journal of Pathology 168, no. 3 (March 2006): 962–72. https://doi.org/10.2353/ajpath.2006.050570.

PMID
16507911
Full Text

Pages